CSF prostaglandin D synthase is reduced in excessive daytime sleepiness

Journal of Neurology

Volumn 253, Issue 8, 2006, Pages 1030-1033

  Bassetti, Claudio L ^a   Hersberger, Martin ^a   Baumann, Christian R ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Betatrace; Excessive daytime sleepiness; Hypersomnia; Narcolepsy; Prostaglandin; Sleep

Indexed keywords

PROSTAGLANDIN D SYNTHASE;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; COMPARATIVE STUDY; DAYTIME SOMNOLENCE; FEMALE; HUMAN; MALE; NEUROCHEMISTRY; PRIORITY JOURNAL;

ADULT; AGED; CASE-CONTROL STUDIES; CATAPLEXY; CHRONIC DISEASE; FEMALE; HUMANS; INTRAMOLECULAR OXIDOREDUCTASES; MALE; MIDDLE AGED; NARCOLEPSY; POLYSOMNOGRAPHY; SLEEP DEPRIVATION; SLEEP STAGES;

EID: 33748955144     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0153-8     Document Type: Article

References (15)

1. Nishino N, Ripley B, Overeem S, Lammers GJ, Mignot E (2000) Hypocretin (orexin) deficiency in human narcolepsy. Lancet 355:39-40
2. Mignot E, Lammers GJ, Ripley B, Okun M, Nevsimalova S, Overeem S, Vankova J, Black J, Harsh J, Bassetti CL, Schrader H, Nishino S (2002) The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 59:1553-62
3. Dauvilliers Y, Baumann CR, Maly F, Torchon F, Bassetti CL (2003) CSF hypocretin-1 levels in narcolepsy, Kleine-Levin syndrome and other hypersomnia and neurological conditions. J Neurol Neurosurg Psychiatry 74:1667-73
4. Urade Y, Hayaishi O (2000) Biochemical, structural, genetic, physiological, and pathophysiological features of lipocalin-type prostaglandine D synthase. Biochimica Biophysica Acta 1482:259-71
5. Jordan WD, Tumani H, Cohrs S, et al (2004) Prostaglandin D synthase (beta-trace) in healthy human sleep. Sleep 27:867-74
6. Pentreath VW, Rees K, Owolabi OA, Philip KA, Doua F (1990) The somnogenic T lymphocyte suppressor prostaglandin D2 is selectively elevated in cerebrospinal fluid of advanced sleeping sickness patients. Trans R Soc Trop Med Hyg 84:795-9
7. American Academy of Sleep Medicine. 2001 International Classification of Sleep Disorders: Diagnostic and Coding Manual, Revised. American Sleep Academy of Sleep Medicine, Rochester, Minn
8. Tumani H, Reiber H, Nau R, Prange HW, Kauffmann K, Mader M, Felgenhauer K (1998) Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis. Neurosci Lett 242:5-8
9. Baumann CR, Dauvilliers Y, Mignot E, Bassetti CL (2004) Normal CSF hypocretin-1 (orexin A) levels in dementia with Lewy bodies associated with excessive daytime sleepiness. Eur Neurol 52:73-6
10. Tibbling G, Link H, Öhman (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37:385-90
11. Jordan W, Tumani H, Cohrs S, Rodenbeck A, Ruther E, Bechthold J, Mayer G (2005) Narcolepsy Increased L-PGDS (beta-trace) levels correlate with excessive daytime sleepiness but not with cataplexy. J Neurol [Epub ahead of print]
12. McArthur J, Hill J, Paech MJ, Dodd PH, Bennett EJ, Holden J (2005) Cerebrospinal fluid and serum concentrations of beta-trace protein during pregnancy. Anaesthesia 60:163-7
13. Tumani H, Nau R, Felgenhauer K (1998) Beta-trace protein in cerebrospinal fluid: a blood-CSF barrier-related evaluation in neurological diseases. Ann Neurol 44:882-9
14. Hayaishi O (2002) Molecular genetic studies on sleep-wake regulation, with special emphasis on the prostaglandin D2 system. J Appl Physiol 92:863-8
15. Grivel J, Cvetkovic V, Bayer L, et al (2005) Wake-promoting hypocretin/orexin neurons change their response to noradrenaline after sleep deprivation. J Neurosci 25:4127-30